Current Treatment Approaches for Transformed Indolent B-Cell Lymphomas |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Pain Management in Oncology |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Cancer Care of the LGBTQ+ Community: Nursing Perspectives |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Acute Myeloid Leukemia: Role of FLT3 Inhibitors After Allogeneic Hematopoietic Cell Transplantation |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Team-Based Case Review: Colorectal Cancer |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Capturing Structured Data in the Electronic Health Record |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Health-Related Social Needs: How to Identify and Address the Needs of Your Patients |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Updates to the Management of HR-Positive, HER2-Negative Breast Cancer |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
NCCN Pharmacy Updates: Advances in Neoadjuvant Treatment Options in Locally Advanced and Metastatic Rectal Cancer with Deficient Mismatch Repair |
1.00 |
10/10/2024 - 12:00am to 03/09/2025 - 12:00am |
NCCN Guidelines® Insights - Systemic Mastocytosis, Version 3.2024 |
1.00 |
06/10/2024 - 12:00am to 06/10/2025 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Oncology Stewardship: Best Practices for Pharmacists in Optimizing Patient Safety and Quality... |
1.00 |
05/02/2024 - 12:00am to 05/02/2025 - 12:00am |
NCCN Guidelines® Insights - Lung Cancer Screening, Version 1.2025 |
1.00 |
01/10/2025 - 12:00am to 01/10/2026 - 12:00am |
Updates in the Management of Neuroblastoma |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Archived NCCN Tumor Boards: Immune Checkpoint Inhibitors for First-Line Therapy in Esophagogastric/Esophagogastric Junction Cancer |
1.00 |
10/28/2024 - 12:00am to 10/28/2025 - 12:00am |
NCCN Guidelines® Insights - Melanoma: Cutaneous, Version 2.2024 |
1.00 |
07/10/2024 - 12:00am to 07/10/2025 - 12:00am |